ClinicalTrials.gg
CompletedNCT07949201Updated Nov 19, 2026

Optimization of Early Mobilization

An interventional study of Early mobilisation in Acute Ischemic Stroke, sponsored by Muğla Sıtkı Koçman University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Muğla Sıtkı Koçman University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Nov 2024, registered Nov 2026).
Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
123
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 54 studies in Ischemic Stroke with a site in Turkey — 12 open to participants now, 16 under way, 1 of them phase 3. Ischemic Stroke · Turkey.

Enrollment
7th of 37
123 · median 50
Started
2024
with 9 others
No phase
32 of 54
9 open now
Registered
54th of 54
by date

Among the 54 studies in Ischemic Stroke with a site in Turkey, this one is the 7th largest by enrollment of the 37 interventional ones that give a count, is one of 10 that started in 2024, is one of 32 with no phase, and was the 54th registered.

Ischemic Stroke

2,629 studies on the registry are indexed under Ischemic Stroke; 983 are open to participants now.

Browse Ischemic Stroke studies →

Open to participants now

12 of the 54 studies in Ischemic Stroke with a site in Turkey are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 668 Ischemic Stroke studies recruiting now, 403 (60%) set no upper age limit and 62 (9%) stop at 75 or younger; 27 take children under 18; 41 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Ischemic Stroke with a site in Turkey, or all of them as a file.
02

Study summary

This study examined how often, how long, and at what level of effort people should practice getting out of bed and moving during their hospital stay after an ischemic stroke. Early mobilization included activities such as sitting at the edge of the bed, standing, moving from the bed to a chair, and walking with help as needed.

In the first stage, 63 participants were randomly assigned to one of nine early mobilization programs that differed in the number of daily sessions, the length of each session, and the level of effort. The researchers used information on recovery, safety, and how much of each program could be delivered to select two programs for further study.

In the second stage, a separate group of 60 participants was randomly assigned to one of the two selected programs or to a comparison program consisting of one 10-minute session of low-intensity mobilization each day. All participants received routine hospital rehabilitation in addition to their assigned program. The study tested whether the selected programs improved how independently participants could carry out daily activities three months after stroke.

Read the detailed description

This single-center, two-stage randomized interventional study evaluated early out-of-bed mobilization during hospitalization in adults with mild to moderate acute ischemic stroke who were clinically stable.

Stage 1 used an L9 orthogonal array to evaluate nine combinations of session frequency (one, two, or three sessions per day), session duration (10, 15, or 20 minutes), and intensity (low, moderate, or high). Sixty-three participants were randomized, with seven participants per program. Two programs were selected for Stage 2 after reviewing the Stage 1 functional outcomes, adverse events, and how closely the delivered mobilization duration matched the planned duration.

In Stage 2, a separate cohort of 60 participants was randomized in a 1:1:1 ratio to Program 7, Program 9, or the low-dose early mobilization control. Physiotherapists delivered the assigned programs during the acute hospital stay alongside routine inpatient physiotherapy and rehabilitation. Activities were tailored to each participant's functional ability and tolerance. In both stages, outcomes were assessed by a physiotherapist who was unaware of group assignments and did not deliver the study intervention.

03

Conditions studied

  • Acute Ischemic Stroke

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older,
  • Having a diagnosis of ischemic stroke within the last 24 hours,
  • Having a mild to moderate stroke (National Institutes of Health Stroke Scale score \<17),
  • Being medically stable (systolic blood pressure 120-180 mmHg, heart rate 50-100 beats/min, body temperature \<37.5 °C, O2 saturation >92%),
  • Having a pre-stroke Modified Rankin Scale score of \<3.

Exclusion criteria

Exclusion criteria:

  • Having a diagnosis of (TIA),
  • Having a diagnosis of hemorrhagic stroke,
  • Having severe heart failure,
  • Decision for intensive care admission or emergency surgery due to a deterioration in the patient's condition,
  • Clinical deterioration as determined by a neurologist,
  • Having any lower extremity injury that would hinder the mobilization protocol,
  • Presence of an unstable coronary condition,
  • Occurrence of a recurrent cerebrovascular event,
  • Worsening in the severity of the disease,
  • Presence of pulmonary embolism,
  • Presence of deep vein thrombosis,
  • Presence of pneumonia,
  • Patient's withdrawal of voluntary participation in the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
123 participants (actual)

Study arms

  • Experimental
    Dose A

    Participants received one 20-minute session of moderate-intensity early mobilisation per day during the acute stroke hospitalization, in addition to routine inpatient physiotherapy and rehabilitation.

    Other: Early mobilisation

  • Experimental
    Dose B

    Participants received three 15-minute sessions of low-intensity early mobilization per day during the acute stroke hospitalization, in addition to routine inpatient physiotherapy and rehabilitation.

    Other: Early mobilisation

  • Active comparator
    Control Dose

    Participants received one 10-minute session of low-intensity early mobilization per day during the acute stroke hospitalization, in addition to routine inpatient physiotherapy and rehabilitation.

    Other: Early mobilisation

Interventions

  • OtherEarly mobilisation

    A physiotherapist delivered active out-of-bed mobilization during the acute stroke hospitalization. Activities included sitting at the edge of the bed, sit-to-stand practice, transfers, standing, stepping, and walking, selected according to the participant's functional ability and tolerance. The physiotherapist monitored physiological responses and the participant's perceived exertion using the Borg Rating of Perceived Exertion scale. Participants also received routine inpatient physiotherapy and rehabilitation.

06

What researchers measure

Primary outcomes

  1. Modified Rankin Scale

    The modified Rankin Scale (mRS) measures global disability after stroke. Scores range from 0 (no symptoms) to 6 (death), with higher scores indicating greater disability. The primary outcome is the distribution of scores across the mRS categories at the 3-month assessment.

    Time frame: 3 months after stroke onset

07

Study locations

1 site
  • Muğla Training Hospital
    Muğla, Menteşe 48000, Turkey (Türkiye)
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in May 2026, 18 months.

Of 576 non-industry interventional studies with no phase under Ischemic Stroke, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's 18 months is below that.

Counting every sponsor, half of 656 studies reached it within 27 months; a quarter within 14 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 15, 2026
First posted
Nov 19, 2026
StartActual
Nov 17, 2024
Primary completionActual
May 22, 2026
CompletionActual
May 22, 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07949201
Responsible party
Asalet Aybuke GUP (Research Assistant, Muğla Sıtkı Koçman University) — Principal investigator
First posted
Nov 19, 2026
Start date
Nov 17, 2024
Primary completion
May 22, 2026
Completion
May 22, 2026
Last update
Nov 19, 2026

Study contacts

Banu BAYAR, PhD
study chair · Muğla Sıtkı Koçman University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion